|
Anyone going to the Breast Cancer Symposium Sept in SF?
Link to the entire agenda:
http://www.asco.org/portal/site/ASCO...00ed730ad1RCRD
There is a session dedicated to Her 2 discussion:
|
Program Agenda
Saturday, September 8, 2007
7:00 AM – 8:00 AM
Breakfast Available and General Poster Session C
7:45 AM – 8:00 AM
Welcome
8:00 AM – 9:45 AM
General Session V: Local Regional Management
- Is Axillary Dissection Needed in Node (+) Breast Cancer?
- Is There a Role for Local Treatment in Metastatic Breast Cancer?
- Is There an Optimal Timing for Radiation Therapy and Reconstruction?
- Partial Breast Irradiation: Biological Underpinnings and Clinical Data
- Does Subtype and Genotype Influence Local Treatment Decisions?
- Can We Use Early Response Assessment to Guide Preoperative Therapy?
General Session VI: HER2 Positive Breast Cancer
- Biology of HER2 (+) Disease/Role of ER
- HER2 Testing
- What is the Role of Chemotherapy with Trastuzumab?
- Tyrosine-Kinase Inhibitors
- Other Anti-HER2 Agents
- Imaging and HER2 Therapy: Targeting and Response
|
|
__________________
Are we there yet?
Dx 10/05 IDC, multi-focal, triple +, 5 nodes+
MRM, 4 DD A/C, 12 weekly taxol + herceptin
rads concurrent with taxol/herceptin
finished herceptin 01/08
ooph, Arimidex, bilateral DIEP reconstruction
NED
Univ. of WA, Seattle vaccine trial '07
|